Back to News
Jun 15, 2026 8:10 AM

Thrombolex Inc Names Michael Tutera, Chief Executive Officer

Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases, announced that the Board of Directors has appointed Michael Tutera as Chief Executive Officer.

New Britain, PA June 15, 2026 --(PR.com)-- Thrombolex, Inc. Names Michael Tutera Chief Executive Officer

Co-founder and current President and CEO, Mike Cerminaro, to remain a member of the Board of Directors

Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases, announced that the Board of Directors has appointed Michael Tutera as Chief Executive Officer. This appointment follows the planned transition of Mike Cerminaro, co-founder and current President & CEO, who will continue to support the Company as a member of the Board of Directors.

Mr. ...